Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
1250 35 39 35 39 B-lower_bound
/ 39 40 39 40 I-lower_bound
ul 40 42 40 42 I-lower_bound

Active 0 6 43 49 O
uncontrolled 7 19 50 62 O
bleeding 20 28 63 71 B-chronic_disease

All 0 3 72 75 O
patients 4 12 76 84 O
must 13 17 85 89 O
have 18 22 90 94 O
diagnostic 23 33 95 105 B-treatment
laparoscopy 34 45 106 117 I-treatment
with 46 50 118 122 O
diagnostic 51 61 123 133 O
washings 62 70 134 142 O
for 71 74 143 146 O
cytology 75 83 147 155 B-treatment

Creatinine 0 10 156 166 B-clinical_variable
= 11 12 167 168 O
< 12 13 168 169 O
1.5 14 17 170 173 B-upper_bound
x 18 19 174 175 I-upper_bound
upper 20 25 176 181 I-upper_bound
limit 26 31 182 187 I-upper_bound
of 32 34 188 190 I-upper_bound
normal 35 41 191 197 I-upper_bound

Diarrhea 0 8 198 206 B-chronic_disease
, 8 9 206 207 O
grade 10 15 208 213 B-lower_bound
1 16 17 214 215 I-lower_bound
or 18 20 216 218 O
greater 21 28 219 226 O
by 29 31 227 229 O
the 32 35 230 233 O
National 36 44 234 242 O
Cancer 45 51 243 249 O
Institute 52 61 250 259 O
Common 62 68 260 266 O
Terminology 69 80 267 278 O
Criteria 81 89 279 287 O
for 90 93 288 291 O
Adverse 94 101 292 299 O
Events 102 108 300 306 O
( 109 110 307 308 O
NCI 110 113 308 311 O
- 113 114 311 312 O
CTCAE 114 119 312 317 O
, 119 120 317 318 O
version 121 128 319 326 O
[ 129 130 327 328 O
v 130 131 328 329 O
] 131 132 329 330 O
4.0 133 136 331 334 O
) 136 137 334 335 O

Eastern 0 7 336 343 B-clinical_variable
Cooperative 8 19 344 355 I-clinical_variable
Oncology 20 28 356 364 I-clinical_variable
Group 29 34 365 370 I-clinical_variable
( 35 36 371 372 I-clinical_variable
ECOG 36 40 372 376 I-clinical_variable
) 40 41 376 377 I-clinical_variable
performance 42 53 378 389 I-clinical_variable
status 54 60 390 396 I-clinical_variable
= 61 62 397 398 O
< 62 63 398 399 O
1 64 65 400 401 B-upper_bound

Eligible 0 8 402 410 O
for 9 12 411 414 O
surgery 13 20 415 422 B-treatment
with 21 25 423 427 I-treatment
curative 26 34 428 436 I-treatment
intent 35 41 437 443 I-treatment

Hemoglobin 0 10 444 454 B-clinical_variable
> 11 12 455 456 O
= 12 13 456 457 O
9 14 15 458 459 B-lower_bound
g 16 17 460 461 I-lower_bound
/ 17 18 461 462 I-lower_bound
dL 18 20 462 464 I-lower_bound

Histologically 0 14 465 479 O
confirmed 15 24 480 489 O
locally 25 32 490 497 O
advanced 33 41 498 506 O
gastric 42 49 507 514 B-cancer
( 50 51 515 516 O
primary 51 58 516 523 O
endpoint 59 67 524 532 O
includes 68 76 533 541 O
proximal 77 85 542 550 O
and 86 89 551 554 O
mid 90 93 555 558 O
- 93 94 558 559 O
body 94 98 559 563 O
stomach 99 106 564 571 O
) 106 107 571 572 O
or 108 110 573 575 O
esophagogastric 111 126 576 591 B-cancer
adenocarcinoma 127 141 592 606 I-cancer
; 141 142 606 607 O
distal 143 149 608 614 O
gastric 150 157 615 622 B-cancer
( 158 159 623 624 I-cancer
antral 159 165 624 630 I-cancer
) 165 166 630 631 I-cancer
adenocarcinomas 167 182 632 647 I-cancer
are 183 186 648 651 O
eligible 187 195 652 660 O
for 196 199 661 664 O
enrolment 200 209 665 674 O
but 210 213 675 678 O
will 214 218 679 683 O
not 219 222 684 687 O
be 223 225 688 690 O
included 226 234 691 699 O
in 235 237 700 702 O
the 238 241 703 706 O
primary 242 249 707 714 O
analysis 250 258 715 723 O

Inflammatory 0 12 724 736 B-chronic_disease
bowel 13 18 737 742 I-chronic_disease
disease 19 26 743 750 I-chronic_disease
that 27 31 751 755 O
is 32 34 756 758 O
uncontrolled 35 47 759 771 O
or 48 50 772 774 O
on 51 53 775 777 O
active 54 60 778 784 O
treatment 61 70 785 794 O
( 71 72 795 796 O
Crohn 72 77 796 801 B-chronic_disease
's 77 79 801 803 I-chronic_disease
disease 80 87 804 811 I-chronic_disease
, 87 88 811 812 O
ulcerative 89 99 813 823 B-chronic_disease
colitis 100 107 824 831 I-chronic_disease
) 107 108 831 832 O

Locally 0 7 833 840 O
advanced 8 16 841 849 O
disease 17 24 850 857 O
as 25 27 858 860 O
determined 28 38 861 871 O
by 39 41 872 874 O
endoscopic 42 52 875 885 B-treatment
ultrasound 53 63 886 896 I-treatment
( 64 65 897 898 I-treatment
EUS 65 68 898 901 I-treatment
) 68 69 901 902 I-treatment
stage 70 75 903 908 O
> 76 77 909 910 O
primary 78 85 911 918 B-cancer
tumor 86 91 919 924 I-cancer
( 92 93 925 926 O
T 93 94 926 927 O
) 94 95 927 928 O
3 96 97 929 930 O
and/or 98 104 931 937 O
any 105 108 938 941 O
T 109 110 942 943 O
, 110 111 943 944 O
lymph 112 117 945 950 O
nodes 118 123 951 956 O
( 124 125 957 958 O
N)+ 125 128 958 961 O
disease 129 136 962 969 O
without 137 144 970 977 O
metastatic 145 155 978 988 B-cancer
disease 156 163 989 996 I-cancer
( 164 165 997 998 O
Mx 165 167 998 1000 O
) 167 168 1000 1001 O

Major 0 5 1002 1007 B-treatment
surgery 6 13 1008 1015 I-treatment
within 14 20 1016 1022 O
4 21 22 1023 1024 B-upper_bound
weeks 23 28 1025 1030 I-upper_bound

Neuropathy 0 10 1031 1041 B-chronic_disease
, 10 11 1041 1042 O
grade 12 17 1043 1048 B-lower_bound
2 18 19 1049 1050 I-lower_bound
or 20 22 1051 1053 O
greater 23 30 1054 1061 O
by 31 33 1062 1064 O
NCI 34 37 1065 1068 O
- 37 38 1068 1069 O
CTCAE 38 43 1069 1074 O
, 43 44 1074 1075 O
v 45 46 1076 1077 O
4.0 47 50 1078 1081 O

Patients 0 8 1082 1090 O
taking 9 15 1091 1097 O
substrates 16 26 1098 1108 B-treatment
, 26 27 1108 1109 O
inhibitors 28 38 1110 1120 B-treatment
, 38 39 1120 1121 O
or 40 42 1122 1124 O
inducers 43 51 1125 1133 B-treatment
of 52 54 1134 1136 I-treatment
cytochrome 55 65 1137 1147 I-treatment
P450 66 70 1148 1152 I-treatment
, 70 71 1152 1153 O
family 72 78 1154 1160 B-treatment
3 79 80 1161 1162 I-treatment
, 80 81 1162 1163 O
subfamily 82 91 1164 1173 B-treatment
A 92 93 1174 1175 I-treatment
, 93 94 1175 1176 O
polypeptide 95 106 1177 1188 B-treatment
4 107 108 1189 1190 I-treatment
( 109 110 1191 1192 I-treatment
CYP3A4 110 116 1192 1198 I-treatment
) 116 117 1198 1199 I-treatment
should 118 124 1200 1206 O
be 125 127 1207 1209 O
encouraged 128 138 1210 1220 O
to 139 141 1221 1223 O
switch 142 148 1224 1230 O
to 149 151 1231 1233 O
alternative 152 163 1234 1245 O
drugs 164 169 1246 1251 O
whenever 170 178 1252 1260 O
possible 179 187 1261 1269 O
, 187 188 1269 1270 O
given 189 194 1271 1276 O
the 195 198 1277 1280 O
potential 199 208 1281 1290 O
for 209 212 1291 1294 O
drug 213 217 1295 1299 O
- 217 218 1299 1300 O
drug 218 222 1300 1304 O
interactions 223 235 1305 1317 O
with 236 240 1318 1322 O
irinotecan 241 251 1323 1333 O

Platelets 0 9 1334 1343 B-clinical_variable
> 10 11 1344 1345 O
= 11 12 1345 1346 O
100,000 13 20 1347 1354 B-lower_bound
/ 20 21 1354 1355 I-lower_bound
ul 21 23 1355 1357 I-lower_bound

Pregnancy 0 9 1358 1367 B-pregnancy

SGOT 0 4 1368 1372 B-clinical_variable
and 5 8 1373 1376 I-clinical_variable
SGPT 9 13 1377 1381 I-clinical_variable
< 14 15 1382 1383 O
5 16 17 1384 1385 B-upper_bound
x 18 19 1386 1387 I-upper_bound
upper 20 25 1388 1393 I-upper_bound
limit 26 31 1394 1399 I-upper_bound
of 32 34 1400 1402 I-upper_bound
normal 35 41 1403 1409 I-upper_bound
for 42 45 1410 1413 O
patients 46 54 1414 1422 O
with 55 59 1423 1427 O
liver 60 65 1428 1433 B-cancer
metastases 66 76 1434 1444 I-cancer

Serious 0 7 1445 1452 O
underlying 8 18 1453 1463 O
medical 19 26 1464 1471 B-chronic_disease
or 27 29 1472 1474 O
psychiatric 30 41 1475 1486 B-chronic_disease
illnesses 42 51 1487 1496 I-chronic_disease
that 52 56 1497 1501 O
would 57 62 1502 1507 O
, 62 63 1507 1508 O
in 64 66 1509 1511 O
the 67 70 1512 1515 O
opinion 71 78 1516 1523 O
of 79 81 1524 1526 O
the 82 85 1527 1530 O
treating 86 94 1531 1539 O
physician 95 104 1540 1549 O
, 104 105 1549 1550 O
substantially 106 119 1551 1564 O
increase 120 128 1565 1573 O
the 129 132 1574 1577 O
risk 133 137 1578 1582 O
for 138 141 1583 1586 O
complications 142 155 1587 1600 O
related 156 163 1601 1608 O
to 164 166 1609 1611 O
treatment 167 176 1612 1621 B-treatment

Serum 0 5 1622 1627 B-clinical_variable
glutamic 6 14 1628 1636 I-clinical_variable
oxaloacetic 15 26 1637 1648 I-clinical_variable
transaminase 27 39 1649 1661 I-clinical_variable
( 40 41 1662 1663 I-clinical_variable
SGOT 41 45 1663 1667 I-clinical_variable
) 45 46 1667 1668 I-clinical_variable
and 47 50 1669 1672 O
serum 51 56 1673 1678 B-clinical_variable
glutamate 57 66 1679 1688 I-clinical_variable
pyruvate 67 75 1689 1697 I-clinical_variable
transaminase 76 88 1698 1710 I-clinical_variable
( 89 90 1711 1712 I-clinical_variable
SGPT 90 94 1712 1716 I-clinical_variable
) 94 95 1716 1717 I-clinical_variable
< 96 97 1718 1719 O
2.5 98 101 1720 1723 B-upper_bound
x 102 103 1724 1725 I-upper_bound
upper 104 109 1726 1731 I-upper_bound
limit 110 115 1732 1737 I-upper_bound
of 116 118 1738 1740 I-upper_bound
normal 119 125 1741 1747 I-upper_bound
for 126 129 1748 1751 O
patients 130 138 1752 1760 O
without 139 146 1761 1768 O
liver 147 152 1769 1774 B-cancer
metastases 153 163 1775 1785 I-cancer

Total 0 5 1786 1791 B-clinical_variable
bilirubin 6 15 1792 1801 I-clinical_variable
< 16 17 1802 1803 O
1.5 18 21 1804 1807 B-upper_bound
x 22 23 1808 1809 I-upper_bound
upper 24 29 1810 1815 I-upper_bound
limit 30 35 1816 1821 I-upper_bound
of 36 38 1822 1824 I-upper_bound
normal 39 45 1825 1831 I-upper_bound

Women 0 5 1832 1837 B-gender
of 6 8 1838 1840 O
child 9 14 1841 1846 O
- 14 15 1846 1847 O
bearing 15 22 1847 1854 O
potential 23 32 1855 1864 O
and 33 36 1865 1868 O
men 37 40 1869 1872 O
must 41 45 1873 1877 O
agree 46 51 1878 1883 B-contraception_consent
to 52 54 1884 1886 I-contraception_consent
use 55 58 1887 1890 I-contraception_consent
adequate 59 67 1891 1899 I-contraception_consent
contraception 68 81 1900 1913 I-contraception_consent
( 82 83 1914 1915 O
hormonal 83 91 1915 1923 B-contraception_consent
or 92 94 1924 1926 O
barrier 95 102 1927 1934 B-contraception_consent
method 103 109 1935 1941 I-contraception_consent
of 110 112 1942 1944 I-contraception_consent
birth 113 118 1945 1950 I-contraception_consent
control 119 126 1951 1958 I-contraception_consent
; 126 127 1958 1959 O
abstinence 128 138 1960 1970 B-contraception_consent
) 138 139 1970 1971 O
prior 140 145 1972 1977 O
to 146 148 1978 1980 O
study 149 154 1981 1986 O
entry 155 160 1987 1992 O
and 161 164 1993 1996 O
for 165 168 1997 2000 O
the 169 172 2001 2004 O
duration 173 181 2005 2013 O
of 182 184 2014 2016 O
study 185 190 2017 2022 O
participation 191 204 2023 2036 O
, 204 205 2036 2037 O
up 206 208 2038 2040 O
until 209 214 2041 2046 O
30 215 217 2047 2049 B-lower_bound
days 218 222 2050 2054 I-lower_bound
after 223 228 2055 2060 O
final 229 234 2061 2066 O
study 235 240 2067 2072 O
treatment 241 250 2073 2082 B-treatment

adequately 0 10 2083 2093 O
treated 11 18 2094 2101 O
basal 19 24 2102 2107 B-cancer
cell 25 29 2108 2112 I-cancer
or 30 32 2113 2115 I-cancer
squamous 33 41 2116 2124 I-cancer
cell 42 46 2125 2129 I-cancer
skin 47 51 2130 2134 I-cancer
cancer 52 58 2135 2141 I-cancer
, 58 59 2141 2142 O
in 60 62 2143 2145 B-cancer
situ 63 67 2146 2150 I-cancer
cervical 68 76 2151 2159 I-cancer
cancer 77 83 2160 2166 I-cancer
, 83 84 2166 2167 O
or 85 87 2168 2170 O
any 88 91 2171 2174 O
other 92 97 2175 2180 O
cancer 98 104 2181 2187 O
for 105 108 2188 2191 O
which 109 114 2192 2197 O
the 115 118 2198 2201 O
patient 119 126 2202 2209 O
has 127 130 2210 2213 O
been 131 135 2214 2218 O
previously 136 146 2219 2229 O
treated 147 154 2230 2237 O
and 155 158 2238 2241 O
the 159 162 2242 2245 O
lifetime 163 171 2246 2254 O
recurrence 172 182 2255 2265 O
risk 183 187 2266 2270 O
is 188 190 2271 2273 O
less 191 195 2274 2278 O
than 196 200 2279 2283 O
30 201 203 2284 2286 B-upper_bound
% 203 204 2286 2287 I-upper_bound

gross 0 5 2288 2293 B-cancer
peritoneal 6 16 2294 2304 I-cancer
disease 17 24 2305 2312 I-cancer

revious 0 7 2313 2320 O
or 8 10 2321 2323 O
concurrent 11 21 2324 2334 B-cancer
malignancy 22 32 2335 2345 I-cancer

should 0 6 2346 2352 O
a 7 8 2353 2354 O
woman 9 14 2355 2360 B-gender
become 15 21 2361 2367 B-pregnancy
pregnant 22 30 2368 2376 I-pregnancy
or 31 33 2377 2379 O
suspect 34 41 2380 2387 B-pregnancy
that 42 46 2388 2392 I-pregnancy
she 47 50 2393 2396 I-pregnancy
is 51 53 2397 2399 I-pregnancy
pregnant 54 62 2400 2408 I-pregnancy
while 63 68 2409 2414 O
participating 69 82 2415 2428 O
in 83 85 2429 2431 O
this 86 90 2432 2436 O
study 91 96 2437 2442 O
, 96 97 2442 2443 O
she 98 101 2444 2447 O
should 102 108 2448 2454 O
inform 109 115 2455 2461 O
her 116 119 2462 2465 O
treating 120 128 2466 2474 O
physician 129 138 2475 2484 O
immediately 139 150 2485 2496 O

